In conclusion, our findings revealed that HJURP, a cross-oncogene, negatively correlated with outcomes of PCa patients, promoted proliferation in PCa cells via inhibition of CDKN1A expression through the GSK3β/JNK signaling pathway. Here, HJURP is linked to posterior cortical atrophy.